Enhanced external counterpulsation (EECP) was used to treat 30 patients with refractory angina due to cardiac Syndrome X, with an initial improvement in CCS angina class (3.57 to 1.43; p<0.001) and regional ischemia in all treated patients. At a mean of 11.9 months follow-up, 87% of patients had sustained improvement in angina and were without MACE. EECP, by improving endothelial function, may be an effective and durable treatment for this often difficult to treat problem. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
机构:
St George Hosp, Sch Med, Dept Cardiovasc Med, Coronary Artery Dis Res Unit, London SW17 0RE, EnglandSt George Hosp, Sch Med, Dept Cardiovasc Med, Coronary Artery Dis Res Unit, London SW17 0RE, England
机构:
St George Hosp, Sch Med, Dept Cardiovasc Med, Coronary Artery Dis Res Unit, London SW17 0RE, EnglandSt George Hosp, Sch Med, Dept Cardiovasc Med, Coronary Artery Dis Res Unit, London SW17 0RE, England